Bladder Drug Mirabegron Exacerbates Atherosclerosis Through Activation of Brown Fat-Mediated Lipolysis

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1901655116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Transcription Factor HLX Controls a Systematic Switch From White to Brown Fat Through Prdm16-Mediated Co-Activation

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Interrelationship of Cyclic AMP, Lipolysis, and Respiration in Brown Fat Cells

American Journal of Physiology-Legacy Content
1973English

Fifty Shades of Brown: Perivascular Fat, Thermogenesis, and Atherosclerosis

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Mirabegron: A Beta-3 Agonist for Overactive Bladder

The Consultant Pharmacist
2014English

Ginsenoside Rb2 Alleviates Obesity by Activation of Brown Fat and Induction of Browning of White Fat

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Activation of the Lipid Droplet Controls the Rate of Lipolysis of Triglycerides in the Insect Fat Body

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Mirabegron as Adjuvant Treatment for Patients With Interstitial Cystitis/Bladder Pain Syndrome

Canadian Urological Association Journal
Urology
2017English

Brown Fat Activation Mitigates Alcohol-Induced Liver Steatosis and Injury in Mice

Journal of Clinical Investigation
Medicine
2019English

Targeting Brown Fat to Make Less Fat

Science
MultidisciplinaryPhilosophy of ScienceHistory
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy